aap Implantate AG (AAQ1.DE) • XETRA
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold AAQ1.DE in your mock portfolio yet.
aap Implantate AG is currently loss-making, as indicated by its negative EPS and PE ratio. The valuation signal (negative PE) suggests the market is pricing in ongoing or near-term losses rather than stable profitability. Without evidence of a clear path to positive earnings, the financial profile remains weak.
The stock has declined 12% over the last month, signaling recent negative momentum, but the current price is only slightly above the 200-day moving average. The RSI near 37 suggests the stock is approaching oversold territory but not yet at an extreme, implying selling pressure may be moderating. Overall, the technical picture is mixed, with neither a clear bullish nor strongly bearish signal in the very near term.
Alternative data for aap Implantate AG is modest in scale and offers mixed signals. Web traffic is low in absolute terms, job openings have declined month over month, and social media growth is positive but small. These indicators do not currently point to strong growth momentum, but they also do not show a sharp deterioration.
Overall, the picture for aap Implantate AG skews bearish, driven primarily by ongoing losses and a lack of clear evidence of improving profitability. Technicals and alternative data are more mixed, offering some signs of potential stabilization but not enough to offset the fundamental weakness. Until there is a visible path to positive earnings and stronger growth signals, the risk-reward profile appears challenged.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Upgrade to see the full Evidence Stack
What Changed, Why Now, and Risk Flags — available on the Investor plan and above
Get Started